Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: June 2017

6/16/2017 Database Update: Pharmaceutical Drug Import to Russia (May 2017)

Between January and May 2017, Russia imported 194.5 bln RUB worth of ready-made drugs (free circulation prices), which is 10.5% higher than that of the same period of 2016. Despite the progress made at the beginning of the year, the import increased by 9.6% in May against nearly 16% in April. As for the in-bulk import, the dynamics were as low as -24.7% in monetary terms, with 35.5 bln RUB.